LC-2
LC-2 is a potent and first-in-class von Hippel-Lindau-based PROTAC capable of degrading endogenous KRAS G12C, with DC50s between 0.25 and 0.76 μM[1]. LC-2 covalently binds KRAS G12C with a MRTX849 warhead and recruits the E3 ligase VHL, inducing rapid and sustained KRAS G12C degradation leading to suppression of MAPK signaling in both homozygous and heterozygous KRAS G12C cell lines[2].
Product Specifications
CAS Number
2502156-03-6
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
PROTACs; Ras
Type
Reference compound
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway; PROTAC
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/protac-krasg12c-degrader-lc-2.html
Purity
98.48
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
Molecular Formula
C59H71ClFN11O7S
Molecular Weight
1132.78
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
K-Ras; von Hippel-Lindau (VHL)
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
](https://cdn.genprice.uk/products/572/12166115/imageurl/trc-n649350-10mg.webp)
7,7’-Nonane-1,9-diylbis[estra-1,3,5(10)-triene-3,17beta-diol](Mixture of Diastereomers)
TRAcP (Tartrate-Resistant Acid Phosphatase) (Hairy Cell Leukemia Marker) (rACP5/1070), CF640R conjugate, 0.1mg/mL
MLH1 (MutL Homolog 1) (MLH1/1324), CF405S conjugate, 0.1mg/mL
(2R,3aR,7aR)-1-(((R)-1-Ethoxy-1-oxopentan-2-yl)-D-alanyl)octahydro-1H-indole-2-carboxylic Acid
![(1R,5R,6R)-rel-5-(1-Ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylic Acid Ethyl Ester](https://cdn.genprice.uk/products/572/7395531868722/imageurl/trc-e925695-25mg.webp)